Crystal form of dabrafenib mesylate and preparation method thereof
US9453011B2 · kind B2 · utility
3Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2015 |
| Grant date | Sep 27, 2016 |
| Priority date | — |
| Expiry date | Oct 28, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention involves novel crystal forms of Dabrafenib mesylate and preparation method thereof, wherein the novel crystal forms are more stable in water or an aqueous system, and have greater solubility and dissolution rate in water, thus having better stability and bioavailability compared with the existing crystal forms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.